DK

Dilip Kumar Pandey

Active Director Director DIN 07530391
DIN 07530391 First appointment May 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 2 historical roles
Total affiliations 3 Since May 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Dilip Kumar Pandey

Data last updated:

Dilip Kumar Pandey is a Director at Smith And Sapphire Bio-Tech Limited (since 2016). The companies operate in Pharma. Earlier, Dilip Kumar Pandey was an Additional Director at Babuji Overseas Private Limited (from 2016) and Director at Sangaria Private Limited (from 2017).

DIN 07530391
Primary Designation Director
Industry Pharma
First Appointment 28 May 2016
Oldest Company Age 31 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Smith And Sapphire Bio-Tech Limited U74899DL1995PLC065063
Director28 May 20161995Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Babuji Overseas Private Limited U51909DL2014PTC270201
Additional Director15 Dec 20162014₹18.3 Lakh (FY 2017)Strike Off
Sangaria Private Limited U74900DL2012PTC240760
Director24 Mar 20172012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Dilip Kumar Pandey

Directorship timeline

Open interactive timeline →
Babuji Overseas Private Limited
Sangaria Private Limited
Smith And Sapphire Bio-Tech Limited
Premium access

Shareholding and investment profile for Dilip Kumar Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dilip Kumar Pandey

Dilip Kumar Pandey currently holds 1 directorship: Smith And Sapphire Bio-Tech Limited (Director, since 28 May 2016).

Dilip Kumar Pandey was first appointed on 28 May 2016 as Director at Smith And Sapphire Bio-Tech Limited. The most recent appointment on record is 24 Mar 2017 at Sangaria Private Limited.

Dilip Kumar Pandey held 2 earlier board appointments: Babuji Overseas Private Limited (Additional Director, from 15 Dec 2016); Sangaria Private Limited (Director, from 24 Mar 2017).

The current boards of Dilip Kumar Pandey's companies include Mahmud Kazi (Smith And Sapphire Bio-Tech Limited), Rohit Choudhary Kumar (Smith And Sapphire Bio-Tech Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available